Click for best price
Hospital Acquired Infections HAI Diagnostics Market Size, Share 2023
| Market size in 2022 |
US$ 3428.4 million
|
Forecast Market size by 2029 |
US$ 4532.7 million
|
| Growth Rate |
CAGR of 4.1% |
Number of Pages |
60 Pages |
Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.
This report aims to provide a comprehensive presentation of the global market for Hospital Acquired Infections (HAI) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Acquired Infections (HAI) Diagnostics. This report contains market size and forecasts of Hospital Acquired Infections (HAI) Diagnostics in global, including the following market information:
Global Hospital Acquired Infections (HAI) Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hospital Acquired Infections (HAI) Diagnostics market was valued at US$ 3428.4 million in 2022 and is projected to reach US$ 4532.7 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis.
We surveyed the Hospital Acquired Infections (HAI) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Acquired Infections (HAI) Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, by Type, 2022 (%)
Molecular Diagnostics Tests
Other In-vitro Diagnostic Tests
Global Hospital Acquired Infections (HAI) Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, by Application, 2022 (%)
Bloodstream Infections (BSI)
Urinary Tract Infections (UTI)
Surgical Site Infections (SSI)
Pneumonia
Others
Global Hospital Acquired Infections (HAI) Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Acquired Infections (HAI) Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hospital Acquired Infections (HAI) Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioM?rieux
Abbott Laboratories
Roche AG
Siemens Healthcare
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hospital Acquired Infections (HAI) Diagnostics, market overview.
Chapter 2: Global Hospital Acquired Infections (HAI) Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Hospital Acquired Infections (HAI) Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital Acquired Infections (HAI) Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hospital Acquired Infections (HAI) Diagnostics Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 3428.4 million
|
| Forecast Market size by 2029 |
US$ 4532.7 million
|
| Growth Rate |
CAGR of 4.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital Acquired Infections (HAI) Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Acquired Infections (HAI) Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital Acquired Infections (HAI) Diagnostics Overall Market Size
2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size: 2022 VS 2029
2.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital Acquired Infections (HAI) Diagnostics Players in Global Market
3.2 Top Global Hospital Acquired Infections (HAI) Diagnostics Companies Ranked by Revenue
3.3 Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Hospital Acquired Infections (HAI) Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hospital Acquired Infections (HAI) Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Hospital Acquired Infections (HAI) Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Molecular Diagnostics Tests
4.1.3 Other In-vitro Diagnostic Tests
4.2 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Market Size, 2022 & 2029
5.1.2 Bloodstream Infections (BSI)
5.1.3 Urinary Tract Infections (UTI)
5.1.4 Surgical Site Infections (SSI)
5.1.5 Pneumonia
5.1.6 Others
5.2 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, 2018-2029
6.3.2 US Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.3.3 Canada Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.3.4 Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, 2018-2029
6.4.2 Germany Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.4.3 France Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.4.4 U.K. Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.4.5 Italy Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.4.6 Russia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.4.8 Benelux Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, 2018-2029
6.5.2 China Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.5.3 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.5.4 South Korea Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.5.6 India Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, 2018-2029
6.6.2 Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.6.3 Argentina Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, 2018-2029
6.7.2 Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.7.3 Israel Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
6.7.5 UAE Hospital Acquired Infections (HAI) Diagnostics Market Size, 2018-2029
7 Hospital Acquired Infections (HAI) Diagnostics Companies Profiles
7.1 BioM?rieux
7.1.1 BioM?rieux Company Summary
7.1.2 BioM?rieux Business Overview
7.1.3 BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.1.4 BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2018-2023)
7.1.5 BioM?rieux Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.2.4 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Roche AG
7.3.1 Roche AG Company Summary
7.3.2 Roche AG Business Overview
7.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.3.4 Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Roche AG Key News & Latest Developments
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Company Summary
7.4.2 Siemens Healthcare Business Overview
7.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.4.4 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Siemens Healthcare Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital Acquired Infections (HAI) Diagnostics Market Opportunities & Trends in Global Market
Table 2. Hospital Acquired Infections (HAI) Diagnostics Market Drivers in Global Market
Table 3. Hospital Acquired Infections (HAI) Diagnostics Market Restraints in Global Market
Table 4. Key Players of Hospital Acquired Infections (HAI) Diagnostics in Global Market
Table 5. Top Hospital Acquired Infections (HAI) Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hospital Acquired Infections (HAI) Diagnostics Product Type
Table 9. List of Global Tier 1 Hospital Acquired Infections (HAI) Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. BioM?rieux Company Summary
Table 31. BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 32. BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. BioM?rieux Key News & Latest Developments
Table 34. Abbott Laboratories Company Summary
Table 35. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 36. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Laboratories Key News & Latest Developments
Table 38. Roche AG Company Summary
Table 39. Roche AG Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 40. Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Roche AG Key News & Latest Developments
Table 42. Siemens Healthcare Company Summary
Table 43. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 44. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Siemens Healthcare Key News & Latest Developments
List of Figures
Figure 1. Hospital Acquired Infections (HAI) Diagnostics Segment by Type in 2022
Figure 2. Hospital Acquired Infections (HAI) Diagnostics Segment by Application in 2022
Figure 3. Global Hospital Acquired Infections (HAI) Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hospital Acquired Infections (HAI) Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2022
Figure 8. By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
